MEDICAL HOLOGRAPHY MARKET ANALYSIS

Medical Holography MarketSize and Trends

Global Medical Holography Market: Dynamics

The primary driver for global medical holography market include increasing applications of holography for clinical use. For instance, according to a news article published by Imaging Technology News on March 21, 2017, it was observed that several leading clinical sites adopted EchoPixel’s True3D, a 3D medical imaging software powered by HP for use in paediatric surgery. In 2017, clinical sites such as Nicklaus Children’s Hospital, Miami and Sick Kids Hospital, Toronto adopted True3D by EchoPixel. In 2017, True3D was incorporated into a 3D lab at Cook Children’s Medical Center, Texas to establish technologically advanced diagnosis and pre-planning of complex heart surgeries. This 3D technology helps surgeons to interact closely with life-size 3D virtual images of human anatomy during real time cardiac procedures.

Rising launches of products by market players is a major factor that is expected to drive growth of the global medical holography market over the forecast period. For instance, in 2017, EchoPixel, Inc., a U.S. medical device manufacturer, launched True3D Viewer software program for medical visualisation. True3D viewer software creates a hyper-realistic environment for the clinician and enables them to interact with the virtual 3D images of the human anatomy the same way as they do with real objects. Moreover, in September 2019, EchoPixel, Inc. announced the launch of an intraoperative software which is the first of its kind. This software assists cardiologists in carrying out complex heart procedures by visualization of 3D medical images in real time. Thus, with the use of such advanced 3D imaging technology surgeons can pre-plan a surgery, understand the anatomic variability involved in cardiac procedures and also deliver personalised procedures specific to a particular patient.

Moreover, the global medical holography market is expected to show potential growth over the forecast period due to rising focus of market players in getting product approvals from regulatory authorities. For instance, in December 2019, Chicago-based Augmedics, a virtual reality solutions company received the U.S Food and Drug Administration (FDA) 510k clearance for the use of its product xvision spine system (XVS).  XVS is a minimally invasive 3D imaging headset used in spinal surgery.